Literature DB >> 25675885

Directed evolution of phenylacetone monooxygenase as an active catalyst for the Baeyer-Villiger conversion of cyclohexanone to caprolactone.

Loreto P Parra1,2,3, Juan P Acevedo1,2,4, Manfred T Reetz5,6.   

Abstract

Phenylacetone monooxygenase (PAMO) is an exceptionally robust Baeyer-Villiger monooxygenase, which makes it ideal for potential industrial applications. However, its substrate scope is limited, unreactive cyclohexanone being a prominent example. Such a limitation is unfortunate, because this particular transformation in an ecologically viable manner would be highly desirable, the lactone and the respective lactam being of considerable interest as monomers in polymer science. We have applied directed evolution in search of an active mutant for this valuable C-C activating reaction. Using iterative saturation mutagenesis (ISM), several active mutants were evolved, with only a minimal trade-off in terms of stability. The best mutants allow for quantitative conversion of 2 mM cyclohexanone within 1 h reaction time. In order to circumvent the NADP(+) regeneration problem, whole E. coli resting cells were successfully applied. Molecular dynamics simulations and induced fit docking throw light on the origin of enhanced PAMO activity. The PAMO mutants constitute ideal starting points for future directed evolution optimization necessary for an industrial process.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Baeyer-Villiger monooxygenase; cyclohexanone; directed evolution; literative saturation mutagenesis; phenylacetone monooxygenase; Ɛ-caprolactone

Mesh:

Substances:

Year:  2015        PMID: 25675885     DOI: 10.1002/bit.25564

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  8 in total

1.  Thirty-degree shift in optimum temperature of a thermophilic lipase by a single-point mutation: effect of serine to threonine mutation on structural flexibility.

Authors:  Monika Sharma; Rakesh Kumar; Ranvir Singh; Jagdeep Kaur
Journal:  Mol Cell Biochem       Date:  2017-02-11       Impact factor: 3.396

2.  Engineering a lipase B from Candida antactica with efficient perhydrolysis performance by eliminating its hydrolase activity.

Authors:  Xu-Ping Wang; Peng-Fei Zhou; Zhi-Gang Li; Bo Yang; Frank Hollmann; Yong-Hua Wang
Journal:  Sci Rep       Date:  2017-03-20       Impact factor: 4.379

3.  Characterization and Crystal Structure of a Robust Cyclohexanone Monooxygenase.

Authors:  Elvira Romero; J Rubén Gómez Castellanos; Andrea Mattevi; Marco W Fraaije
Journal:  Angew Chem Int Ed Engl       Date:  2016-11-22       Impact factor: 15.336

4.  Improving catalytic activity of the Baeyer-Villiger monooxygenase-based Escherichia coli biocatalysts for the overproduction of (Z)-11-(heptanoyloxy)undec-9-enoic acid from ricinoleic acid.

Authors:  Ji-Min Woo; Eun-Yeong Jeon; Eun-Ji Seo; Joo-Hyun Seo; Dong-Yup Lee; Young Joo Yeon; Jin-Byung Park
Journal:  Sci Rep       Date:  2018-07-06       Impact factor: 4.379

5.  Stabilization of cyclohexanone monooxygenase by computational and experimental library design.

Authors:  Maximilian J L J Fürst; Marjon Boonstra; Selle Bandstra; Marco W Fraaije
Journal:  Biotechnol Bioeng       Date:  2019-06-24       Impact factor: 4.530

6.  Engineering of Baeyer-Villiger monooxygenase-based Escherichia coli biocatalyst for large scale biotransformation of ricinoleic acid into (Z)-11-(heptanoyloxy)undec-9-enoic acid.

Authors:  Joo-Hyun Seo; Hwan-Hee Kim; Eun-Yeong Jeon; Young-Ha Song; Chul-Soo Shin; Jin-Byung Park
Journal:  Sci Rep       Date:  2016-06-17       Impact factor: 4.379

Review 7.  Biocatalytic synthesis of lactones and lactams.

Authors:  Frank Hollmann; Selin Kara; Diederik J Opperman; Yonghua Wang
Journal:  Chem Asian J       Date:  2018-10-18

8.  Side-Chain Pruning Has Limited Impact on Substrate Preference in a Promiscuous Enzyme.

Authors:  Maximilian J L J Fürst; Elvira Romero; J Rúben Gómez Castellanos; Marco W Fraaije; Andrea Mattevi
Journal:  ACS Catal       Date:  2018-10-30       Impact factor: 13.084

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.